Literature DB >> 28179428

Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01: BREAKING CONFINEMENT.

Soumya G Remesh1, Massimo Andreatta2,3, Ge Ying1, Thomas Kaever2, Morten Nielsen3,4, Curtis McMurtrey5,6, William Hildebrand5,6, Bjoern Peters2, Dirk M Zajonc7,8.   

Abstract

Peptide antigen presentation by major histocompatibility complex (MHC) class I proteins initiates CD8+ T cell-mediated immunity against pathogens and cancers. MHC I molecules typically bind peptides with 9 amino acids in length with both ends tucked inside the major A and F binding pockets. It has been known for a while that longer peptides can also bind by either bulging out of the groove in the middle of the peptide or by binding in a zigzag fashion inside the groove. In a recent study, we identified an alternative binding conformation of naturally occurring peptides from Toxoplasma gondii bound by HLA-A*02:01. These peptides were extended at the C terminus (PΩ) and contained charged amino acids not more than 3 residues after the anchor amino acid at PΩ, which enabled them to open the F pocket and expose their C-terminal extension into the solvent. Here, we show that the mechanism of F pocket opening is dictated by the charge of the first charged amino acid found within the extension. Although positively charged amino acids result in the Tyr-84 swing, amino acids that are negatively charged induce a not previously described Lys-146 lift. Furthermore, we demonstrate that the peptides with alternative binding modes have properties that fit very poorly to the conventional MHC class I pathway and suggest they are presented via alternative means, potentially including cross-presentation via the MHC class II pathway.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  T-cell receptor (TCR); Toxoplasma gondii; antigen presentation; major histocompatibility complex (MHC); natural killer cells (NK cells); peptide interaction; protein crystallization; protein structure

Mesh:

Substances:

Year:  2017        PMID: 28179428      PMCID: PMC5392673          DOI: 10.1074/jbc.M117.776542

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Toxoplasma gondii and MHC-restricted antigen presentation: on degradation, transport and modulation.

Authors:  C G Lüder; F Seeber
Journal:  Int J Parasitol       Date:  2001-10       Impact factor: 3.981

Review 2.  Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future.

Authors:  Eric Vivier; Nicolas Anfossi
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

3.  Have we cut ourselves too short in mapping CTL epitopes?

Authors:  Scott R Burrows; Jamie Rossjohn; James McCluskey
Journal:  Trends Immunol       Date:  2005-11-16       Impact factor: 16.687

4.  Toxoplasmosis in patients with cancer.

Authors:  D M Israelski; J S Remington
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

Review 5.  Toxoplasmic encephalitis in AIDS.

Authors:  B J Luft; J S Remington
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.

Authors:  F T Hakim; R T Gazzinelli; E Denkers; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

8.  Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response.

Authors:  M Deckert-Schlüter; D Schlüter; D Schmidt; G Schwendemann; O D Wiestler; H Hof
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

9.  The immune epitope database (IEDB) 3.0.

Authors:  Randi Vita; James A Overton; Jason A Greenbaum; Julia Ponomarenko; Jason D Clark; Jason R Cantrell; Daniel K Wheeler; Joseph L Gabbard; Deborah Hix; Alessandro Sette; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2014-10-09       Impact factor: 16.971

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  25 in total

1.  Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.

Authors:  Massimo Andreatta; Vanessa I Jurtz; Thomas Kaever; Alessandro Sette; Bjoern Peters; Morten Nielsen
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

2.  Overlapping Peptides Elicit Distinct CD8+ T Cell Responses following Influenza A Virus Infection.

Authors:  Lisa M Assmus; Jing Guan; Ting Wu; Carine Farenc; Xavier Y X Sng; Pirooz Zareie; Angela Nguyen; Andrea T Nguyen; David C Tscharke; Paul G Thomas; Jamie Rossjohn; Stephanie Gras; Nathan P Croft; Anthony W Purcell; Nicole L La Gruta
Journal:  J Immunol       Date:  2020-08-31       Impact factor: 5.422

3.  A systematic re-examination of processing of MHCI-bound antigenic peptide precursors by endoplasmic reticulum aminopeptidase 1.

Authors:  George Mavridis; Richa Arya; Alexander Domnick; Jerome Zoidakis; Manousos Makridakis; Antonia Vlahou; Anastasia Mpakali; Angelos Lelis; Dimitris Georgiadis; Robert Tampé; Athanasios Papakyriakou; Lawrence J Stern; Efstratios Stratikos
Journal:  J Biol Chem       Date:  2020-03-17       Impact factor: 5.157

Review 4.  Antigen processing and presentation in HIV infection.

Authors:  Julie Boucau; Sylvie Le Gall
Journal:  Mol Immunol       Date:  2018-04-07       Impact factor: 4.407

5.  The C-terminal extension landscape of naturally presented HLA-I ligands.

Authors:  Philippe Guillaume; Sarah Picaud; Petra Baumgaertner; Nicole Montandon; Julien Schmidt; Daniel E Speiser; George Coukos; Michal Bassani-Sternberg; Panagis Filippakopoulos; David Gfeller
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-30       Impact factor: 11.205

6.  A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.

Authors:  Jugmohit S Toor; Arjun A Rao; Andrew C McShan; Mark Yarmarkovich; Santrupti Nerli; Karissa Yamaguchi; Ada A Madejska; Son Nguyen; Sarvind Tripathi; John M Maris; Sofie R Salama; David Haussler; Nikolaos G Sgourakis
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

7.  Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.

Authors:  Thomas Partridge; Annalisa Nicastri; Anna E Kliszczak; Louis-Marie Yindom; Benedikt M Kessler; Nicola Ternette; Persephone Borrow
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

Review 8.  Predicting Antigen Presentation-What Could We Learn From a Million Peptides?

Authors:  David Gfeller; Michal Bassani-Sternberg
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

9.  Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First.

Authors:  Yanan Wu; Nianzhi Zhang; Keiichiro Hashimoto; Chun Xia; Johannes M Dijkstra
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

10.  High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.

Authors:  Chloe Chong; Fabio Marino; HuiSong Pak; Julien Racle; Roy T Daniel; Markus Müller; David Gfeller; George Coukos; Michal Bassani-Sternberg
Journal:  Mol Cell Proteomics       Date:  2017-12-14       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.